invivodata Announces Availability of Web-Based ePRO Solution
invivodata inc. announced the availability of DiaryPRO® Web, its Web-based electronic PRO (ePRO) data collection solution. An extension of invivodata’s handheld ePRO solution (DiaryPRO® 170 Smartphone), DiaryPRO Web provides all of the scientific design and ease-of-use features necessary for capturing valid, reliable patient data in a Web interface. DiaryPRO Web’s patient interface and electronic assessment capabilities, combined with the ability to run on any personal computer with a Web browser, aims to give the power and flexibility to deliver quality data and increased study efficiencies without deploying devices to allpatients.
“DiaryPRO Web shares many of the same design and service elements that have been used in hundreds of DiaryPRO handheld trials to date, including integration with EPX™, our ePRO management system”, said Doug Engfer, President and CEO of invivodata. “We designed DiaryPRO Web primarily to meet the needs of clinical trial sponsors conducting late stage and post-marketing research, where hundreds or thousands of patients are required to collect the safety or efficacy data necessary for post-approval analysis.”
Because the considerations for using a Web-based ePRO solution are different than those using a handheld ePRO solution, invivodata offers scientific and regulatory support to clinical researchers as they make critical decisions about their ePRO modality options.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
